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Abstract
Background—Blood pressure is directly and causally associated with body mass index (BMI) in
populations worldwide. However, the relationship may vary across BMI in populations of African
origin.
Methods—We compared the relationship between blood pressure and BMI in populations of
African origin, using thirteen samples from Africa, the Caribbean, UK and USA. We had access to
data from individual participants for age, height, weight, blood pressure and treatment of
hypertension. Analysis was restricted to 18,072 participants (age 35-64 years; 44% men). We
carried out multivariate regression analysis to estimate the relationship between blood pressure
and BMI by country and by sex. The use of anti-hypertensive treatment was taken into account by
exclusion and by sensitivity analysis.
Results—There was a positive relationship between both systolic and diastolic blood pressure
and BMI. In men the slopes for systolic blood pressure varied from 0.27 mm Hg per kg/m2 (95%
confidence interval = −0.01 to 0.56) in the US to 1.72 (0.92 to 2.53) in Ghana (Kumasi). In
women, the slopes varied from 0.08 (−0.54 to 0.72) in South Africa to 1.32 (0.98 to 1.66) in the
Republic of Congo. Similar variation in trends was seen for diastolic blood pressure. The higher
the BMI, the shallower the slopes (−0.10 (−0.15 to −0.06) for systolic, −0−09 (−0.12 to −0.06) for
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diastolic). No differences were seen after excluding persons who were being treated for
hypertension.
Conclusions—Blood pressure and BMI levels vary among populations of the African diaspora.
The effect of BMI on blood pressure levels diminishes as BMI increases. These results suggest a
complex relationship between excess body weight, adiposity and energy expenditure.
Hypertension affects more than a quarter of the world's adult population and this proportion
is likely to reach 29% by 2025.1 Most of this increase will occur in developing countries.
Obesity is reaching epidemic proportions in the industrialized world2 and contributes to
morbidity and mortality.3 Although obesity is less prevalent in developed countries, it is
increasing with urbanization.2
There is a positive association between measures of obesity and blood pressure in both
developed4 and less developed countries.5-6 In high-income countries, the prevalence of
obesity and hypertension increase with increasing urbanization, Blood pressure is positively
related to body mass index (BMI) in people of both European and African origin in
developed countries. People of African origin living in developed countries have a higher
mean BMI than their counterparts in Africa.6-7 A number of studies from a wide range of
environments in low, medium and high income countries indicate that the association
between BMI and levels of blood pressure is constant. However, other study results suggest
this relationship is not constant, but varies in populations at the extremes of the BMI
distribution.
Combining studies from countries across Africa and the African Diaspora gives the
opportunity to shed new light on this question. During the past decade, several population-
based and community-based studies have been carried out in people of African origin living
in Africa, the Caribbean, the United Kingdom and the United States. Where measurements
are conducted similarly, these studies offer an opportunity to make international
comparisons in populations with differing environmental exposures and differing levels of
obesity.6 The aim of this collaborative analysis of 13 studies was to study the relationship
between blood pressure and BMI across a wide range of average levels of BMI,
hypertension and obesity8-11 in people of African origin living in rural and urban Africa,
the Caribbean, UK and US.
METHODS
Study design
We identified 13 surveys conducted between 1988 and 2004 that collected standardized data
on blood pressure, its treatment, and height and weight. Samples from Barbados, St Lucia,
Jamaica, Cameroon and Nigeria were obtained from the International Collaborative Study
on Hypertension.7 Samples from Ghana were taken from two separate studies in Accra12
and in Kumasi.13 The sample from Congo was obtained from a population survey carried
out within the framework of WHO STEPS (courtesy of Prof G Kimbally Kaki). The sample
from Tanzania was obtained from a national study,14 and the sample from South Africa was
obtained from the SASPI 1 survey.15 The Seychelles sample was obtained from the
Seychelles Heart Study II, the UK sample from the Wandsworth Heart & Stroke Study16
and the US sample from the National Health Examination and Nutrition Survey III
(available for public use through the National Center for Health Statistics).17 The studies
were identified in 2004 at a meeting held in Lausanne.7, 12-17 Soon afterwards, the
principal investigators were invited to provide raw data on selected variables. Thirteen
studies were included, and 3 investigators did not respond. We also exclude 5 studies
published after 2004.18-25 Each collaborator provided individual data on sex, age, systolic
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and diastolic blood pressure, height (in cm) and weight (in kg) (to calculate BMI [in kg/
m2]),treatment of hypertension, and details on how blood pressure was measured.
Some of the studies were based on a random probability sample of the whole nation,
whereas others were a series of regional or local samples (Table 1). The age distribution of
participants in the original surveys varied from 18 to 80 years; we restricted our analysis to
those aged 35-64 years. Collectively, the studies enrolled 18,072 participants (44% men)
aged 35-64 years, with the number of participants in individual studies varying from 249 to
3,703. The participation rate varied from 54% to greater than 90%. BMI was the only
measure of body size consistently available across all populations. We defined obesity as a
BMI of 30kg/m2 or greater.
Blood pressure measurement and definition of hypertension
A mercury sphygmomanometer was used for blood pressure measurements in the majority
of studies, except in UK, Ghana (Kumasi), Tanzania, Seychelles and South Africa where
automated devices were used (Table 1). Cuff sizes varied according to arm circumference,
following standard protocols. All studies had at least two measurements, and the second (or
the average of the last two measurements, if more than two were taken) was used to create
the mean for the analyses. The rest period before blood pressure was taken was at least 5
minutes (Table 1). Standardization of blood pressure measurements with the mercury
sphygmomanometer was carried out in the International Collaborative Study,26 Electronic
devices used in other studies had been validated independently, thus enhancing the
comparability of hypertension prevalence studies.27
A person was considered hypertensive if the systolic pressure was ≥140 mmHg, or the
diastolic ≥90 mmHg, or the person reported current use of anti-hypertensive medication.
The number of people on anti-hypertensive therapy was not known for Nigeria and
Cameroon; the use of medication is very uncommon in these countries, and was therefore
assumed to be zero.
Data analysis
We report results as means, with 95% confidence intervals (CI). We used linear regression
to calculate age-adjusted mean systolic and diastolic blood pressure and BMI, within sex
and country, using 45 years as the reference age. We used linear regression to estimate the
age-adjusted relationship between blood pressure and BMI for each country and each sex.
Quadratic terms were also modelled. We calculated age-adjusted prevalence of hypertension
and obesity using direct standardization to the WHO population in 5-year age bands. We
divided the data into age groups (35-44, 45-54, 55-64) to present data graphically. We
plotted regression coefficients for blood pressure against mean BMI (adjusted for age and
sex) weighting the points by the inverse of the variance. A random-effects model was used
to estimate the relationship between the regression coefficients and mean BMI, weighting by
the inverse of the variance. This procedure allows for different sample sizes to contribute
unequally to the final estimate by giving more weight to larger studies. To estimate how
much the treatment of high blood pressure would be likely to reduce the relationship
between blood pressure and BMI, we carried out a sensitivity analysis adjusting the blood
pressure of those on treatment by a random amount (10, 15, 20 and 25 mm Hg). It was
assumed that the effect of treatment would be randomly distributed and the SD would be
equal to 0.5 of the mean.
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RESULTS
Characteristics of the populations
There was heterogeneity in age-adjusted levels of systolic and diastolic blood pressure
among countries in both men (eTable 1a) and women (eTable 1b) (tables available with the
online version of this article). Systolic blood pressure increased with age in all countries.
This relationship could be seen in the African countries as well as in the Caribbean, US, and
UK. The relationship of diastolic blood pressure with age followed a similar pattern. There
was also heterogeneity in age-adjusted levels of BMI across countries (Table 2). There was
no apparent relationship between BMI and age across countries. We found wide variation in
the prevalence of high blood pressure, both across all the countries studied and within the
African countries (Table 2). The proportion of patients using therapy for hypertension also
varied (Table 2). The prevalence of obesity was lowest in African countries, (Table 2) with
the leanest populations in Nigeria and Ghana (Kumasi). The prevalence of obesity was
lower in men than women across the world.
Relationship between blood pressure and BMI
There was marked heterogeneity both by sex and by country in the age-adjusted regression
coefficients of change in blood pressure per unit change in BMI (Tables 3a and 3b). The
slopes in men varied from 0.27 mmHg systolic blood pressure per unit of BMI in the US to
1.72 in Kumasi and in women from 0.08 in South Africa to 1.32 in the Republic of Congo.
In most countries the relationship was direct, but with large variations (Table 3a and 3b).
Roughly 5 to 20% of the variation in blood pressure was explained by BMI in different
settings (Table 3a and 3b).
The relationship between blood pressure and BMI depended on the degree of overweight.
The greater the mean BMI of the populations studied, the shallower the relationships
between blood pressure and BMI (Figure 1). This was consistent for both systolic and
diastolic blood pressure and was independent of the proportion of people being treated for
high blood pressure (Table 4 and Figure 2). Quadratic terms did not add to the fit of the
models in the majority of sites. Finally, sensitivity analysis indicates that if average
treatment effect was as large as 25 mmHg, the results would persist but with an attenuation
of the regression coefficient of up to 20% for systolic and 50% for diastolic blood pressure
(Table 5).
DISCUSSION
We found a wide variation both in the prevalence of hypertension and in the relationship
between blood pressure and BMI across populations of African origin living in different
environments. As BMI increases, so the relationship between blood pressure and BMI
weakens.
This is a pooled analysis of data from studies in diverse populations, including over 18,000
individuals of African descent living in Africa, the Caribbean, US and UK. Methods for
measuring blood pressure were not fully comparable between studies. However, the
adoption of more standardized protocols in recent years has improved the quality of
epidemiologic studies of hypertension in populations of African descent, and we were able
to identify a reasonable number of population-based studies that had used stringent
standardized methods. Comparison of within-population parameters is less biased, and the
data demonstrate a highly heterogeneous relationship between BMI and blood pressure with
decreasing slope as the average BMI of the population increases.
Cappuccio et al. Page 4
Epidemiology. Author manuscript; available in PMC 2010 March 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Blood pressure levels are the strongest predictors of stroke incidence within populations. In
general, the stroke burden across the sampled countries is consistent with our hypertension
prevalence estimates.28 Since there are no incidence data on stroke and only limited
mortality data in sub-Saharan Africa, we were not able to validate the differences in blood
pressure between countries by comparison with differences in stroke rates.
This analysis confirms previous suggestions of a wide variation in blood pressure levels,29
prevalence of hypertension,7 levels of BMI and prevalence of obesity30 in populations of
black African origin. The evidence presented from African populations living in starkly
contrasting environments argues for the influence of environment rather than genetic
inheritance31 as the main determinant of variation in blood pressure and BMI.
A novel finding is the wide variation in the strength of the relationship between blood
pressure and BMI among populations. BMI is an indirect measure of body composition. The
percentage of body fat for a given BMI is higher in women than in men, and in those with
sedentary compared with active lifestyles. It is possible that the differences we observed
may be explained by the measure of fatness.32 Other measures such as waist circumference
or waist-to-hip ratio are regarded as better estimates of abdominal adiposity. However, in
prior studies of populations of African origin, the percentage of body fat as measured by
bio-electrical impedance or by measurement of waist circumference was not a better
predictor of blood pressure28 than BMI.29-30
Limitations
The study has several limitations. First, not all published African population samples are
included. Some investigators declined to participate, and some studies became available too
late to be included. While this may limit the representativeness and generalizability of
prevalence rates, it is unlikely to affect the validity of the pooled or meta-regression
analyses. Second, as stated earlier, heterogeneity in the methods for measuring blood
pressure may have introduced possibly bias in the prevalence estimates. Howeve, it is
unlikely this would have biased the ”within-population” estimates of the relationships
between blood pressure and BMI. Furthermore, the large majority of studies underwent
validations and all used standardized methods. Third, the studies are cross-sectional, hence
inference on causality is not possible. Fourth, the studies were carried out over a more than
15 year time-span. From recent results within a population,36 it may be argued that the
shallower relationships across populations may be due to the differences in time. In our
study the regression coefficients did not vary by the time of the study.
Implications
Attempts to relate body composition to blood pressure extend back the mid-20th century.
Given the high correlation between lean and fat mass37 and the limited accuracy of methods
available for field research, it remains unclear which component is more important in
determining blood pressure. Recent evidence demonstrates an independent association of
resting energy expenditure and blood pressure, unconfounded by BMI or adiposity.38 Since
resting energy expenditure is primarily determined by lean mass,37-38 these findings
suggest that increase in muscle mass, physiologically linked to increased body size, is the
primary factor. Body composition changes linearly over the range of BMI, with higher
percent body fat observed at the upper end of the distribution.37 Thus, increases in relative
weight among the obese will reflect larger gains in adipose tissue relative to lean mass,
compared with the lower end of the BMI distribution. The smaller increases in metabolically
active fat-free body mass would therefore lead to smaller increments in blood pressure per
unit change in BMI in obese groups, consistent with what we observed here. This effect is
unlikely to be biased by changes in the pattern of energy expenditure itself since resting
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energy expenditure, corrected for lean mass, does not differ between rural Nigerians and US
blacks.39 This mechanism would be sufficient to explain why the slopes of blood pressure
on BMI flatten as BMI increases, since it is resting energy expenditure that is associated
with blood pressure. More research is needed to clarify these metabolic mechanisms.
Several other models have been suggested to explain the association between adiposity and
blood pressure, including neuroendocrine abnormalities and enhanced sympathetic nervous
system activity. One model suggests that the increase in blood pressure seen with excess
weight gain may be due to the release of angiotensinogen from adipocytes, leading to an
increased production of angiotensin II, an increase in blood volume and blood pressure.
Since people of black African ancestry tend to be low-renin individuals,40 with blunted
responses to stimulations of the renin-angiotensin-aldosterone system, our results may be
compatible with a blunting of this mechanism as BMI increases.
We have observed contrasts in the slope of the relationship between BMI and blood pressure
in a range of populations from Africa and the African diaspora. Smaller increments in lean
mass are observed in the obese per unit change in BMI, and this could be the underlying
physiologic mechanism explaining our observation. As suggested in previous research,38
this interpretation would alter the standard view that increasing fat mass, per se, is the cause
of increased hypertension risk in obese people of African descent.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
Relationship between the change in systolic (top) and diastolic (bottom) blood pressure with
BMI and the average BMI in men (n=7,893; triangles) and women (n=10,179; circles) aged
35-64 years in populations of African descent across the world. Size of symbols proportional
to sample size.
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Fig 2.
Relationship between the change in systolic (top) and diastolic (bottom) blood pressure with
BMI and the average BMI in untreated men (n=7,347; triangles) and untreated women
(n=9,163; circles) aged 35-64 years in populations of African descent across the world. Size
of symbols proportional to sample size.
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Table 4
Meta-regression of slope of blood pressure on body mass index in each country by sex against mean body
mass index for sex and country.
Systolic blood pressure
β (95% CI)
Diastolic blood pressure
β (95% CI)
Both sexes (n=17,972) −0.10 (−0.15 to −0.06) −0.09 (−0.12 to −0.06)
 Untreated only ((n=16,510) −0.11 (−0.16 to −0.06) −0.08 (−0.11 to −0.05)
Men (n=7,893) −0.17 (−0.26 to −0.08) −0.10 (−0.16 to −0.04)
 Untreated only (n=7,347) −0.18 (−0.28 to −0.08) −0.09 (−0.16 to −0.03)
Women (n=10,179) −0.06 (−0.11 to −0.00) −0.06 (−0.10 to −0.02)
 Untreated only (n=9,163) −0.06 (−0.13 to 0) −0.07 (−0.11 to −0.03)
Interaction between sexes p=0.042 (systolic blood pressure) p=0.17 (diastolic blood pressure) without adjustment for anti-hypertensive therapy.
Interaction between sexes p=0.054 (SBP) p=0.52 (DBP) in untreated only.
Model 1: blood pressure = β0 + β1age + β2BMI within country and sex strata.
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Table 5
Sensitivity analysis for effect of anti-hypertensive treatment. Meta-regression of slope of blood pressure on
body mass index in each country by sex against mean body mass index for sex and country (7,893 men and
10,179 women).
Systolic blood pressure Diastolic blood pressure
No adjustment −0.10 (−0.15 to −0.06) −0.09 (−0.12 to −0.06)
10 mm Hg −0.09 (−0.14 to −0.04) −0.07 (−0.10 to −0.04)
15 mm Hg −0.09 (−0.14 to −0.04) −0.06 (−0.10 to −0.03)
20 mm Hg −0.08 (−0.13 to −0.03) −0.06 (−0.09 to −0.02)
25 mm Hg −0.08 (−0.13 to −0.03) −0.05 (−0.09 to −0.02)
Patients on anti-hypertensive therapy have blood pressure adjusted by random amount from a normal distribution with mean 10, 15, 20 and 25 mm
Hg and SD equal to 0.5 × mean.
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